The establishment of acute GVHD monitoring system based on biomarkers in pediatric hematopoietic stem cell transplantation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100049257

Enrollment

Unknown

Registered

2021-07-28

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

graft versus host disease (GVHD)

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

0.3 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Under the age of 18; 2. Accept HLA full sibling, unrelated (8~10/10 congruence), haploidentical or cord blood donor allogeneic hematopoietic stem cell transplantation; 3. ECOG score 0-2 points; 4. No previous history of neurological disease and/or psychiatric disease; 5. The patients (or their legal representatives) signed the informed consent.

Exclusion criteria

Exclusion criteria: The expected life time is less than 3 months.

Design outcomes

Primary

Measure	Time frame
Rate of acute GVHD;	—

Countries

China

Contacts

Public ContactXu Xiaojun

Children's Hospital of Zhejiang University School of Medicine

medico-xxj@163.com+86 13858067554

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026